Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.20−0.15 (-42.59%)
Close on Nov 13, 2026Market cap $906.90KP/E –Yield –
Oragenics profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Oragenics's profit margin for the twelve months ending Dec 31, 2023 was -54858.1%. For fiscal 2023 it was -54858.1%, against -10864.0% the year before. The highest annual figure on record is -531.6% in fiscal 2011.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -54858.1% | −43994.2 |
| FY2022 | Dec 31, 2022 | -10864.0% | +7198.1 |
| FY2021 | Dec 31, 2021 | -18062.0% | −17446.1 |
| FY2014 | Dec 31, 2014 | -616.0% | +940.7 |
| FY2013 | Dec 31, 2013 | -1556.7% | −573.8 |
| FY2012 | Dec 31, 2012 | -982.9% | −451.3 |
| FY2011 | Dec 31, 2011 | -531.6% | +64.7 |
| FY2010 | Dec 31, 2010 | -596.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2023 | Sep 30, 2023 | -26960.7% | −15149.5 |
| Q2 FY2023 | Jun 30, 2023 | -23175.5% | +7262.7 |
| Q1 FY2023 | Mar 31, 2023 | -16710.7% | – |
| Q3 FY2022 | Sep 30, 2022 | -4497.7% | – |
| Q2 FY2022 | Jun 30, 2022 | -11811.2% | – |
| Q1 FY2022 | Mar 31, 2022 | -30438.2% | – |
See a number that looks wrong?